Luminescence properties of terbium complexes
the synthesis of 2-phenoxyacetohydrazide 3′a is given for illus-
tration. Ethyl phenoxyacetate (0.01 mol, 1.80 g), 5 mL of hydra-
zine hydrate (80%) and 30 mL of absolute ethanol were added
to a 100-mL three-neck flask with stirring; the reaction mixture
was then refluxed for 6 h at 85°C. After cooling to room temper-
ature, white needle-shaped crystals were obtained, filtered and
washed thoroughly with ethanol, and then dried under vacuum
to give compound 3′a.
washed with absolute ethanol, then dried under vacuum to give
compound L1.
(E)-N′-(1-(3-methyl-5-oxo-1-phenyl-4,5-dihydro-1H-pyrazol-4-yl)ethyli-
dene)-2-phenoxyacetohydrazide (L1). A pale yellow needle-shaped
crystal. Yield 71%. m.p. 160–162°C. 1H NMR (CDCl3) δ/ppm: 12.36
(s, 1H, OH of enol-isomer), 8.84 (s, 1H, NH), 7.99 (d, J = 8.0Hz, 2H,
ArH), 7.37 (q, J = 8.1Hz, 4H, ArH), 7.16 (t, J = 7.4Hz, 1H, ArH), 7.11
(t, J = 7.4Hz, 1H, ArH), 6.99 (d, J = 8.0 Hz, 2H, ArH), 4.69 (s, 2H,
CH2), 2.39 (s, 3H, CH3), 2.27 (s, 3H, CH3); 13C NMR (CDCl3)
δ/ppm: 167.67 (C=O), 166.60 (C5 of pyrazolone ring), 165.25
(C3 of pyrazolone ring), 156.84 (C1 of phenoxyl), 147.50 (C=N),
138.66 (C1 of 1-substituted aromatic ring), 129.90, 128.79,
124.70, 122.49, 119.22, 114.58 (aromatic ring carbons), 99.92
(CH2), 66.79 (C4 of pyrazolone ring), 17.16 (CH3), 14.25 (CH3); IR
(KBr) ν/cmꢀ1: 3426, 3211, 2981, 1711, 1617, 1589, 1487, 1374,
1214, 756; MS (EI) m/z (%): 366 (M + 2, 4), 365 (M + 1, 36), 364
(M, 100), 257 (46), 243 (18), 215 (26), 199 (59), 185 (12), 123
(17), 107 (14), 91 (10), 77 (46), 67 (11); Anal. calcd for
C20H20N4O3: C, 65.92; H, 5.53; N, 15.38. Found: C, 65.78; H, 5.47;
N, 15.44.
2-Phenoxyacetohydrazide (3′a). A white needle-shaped crystal. Yield
88%. 1H NMR (CDCl3) δ/ppm: 7.80 (s, 1H, NH), 7.35 (t, J=7.9Hz, 2H,
ArH), 7.06 (t, J= 7.4 Hz, 1H, ArH), 6.93 (d, J= 8.5 Hz, 2H, ArH), 4.61
(s, 2H, CH2), 3.93 (s, 2H, NH2); MS (EI) m/z (%): 167 (M + 1, 4), 166
(M, 34), 135 (2), 134 (8), 108 (4), 107 (23), 94 (100), 77 (62), 65 (6).
p-Methyl-2-phenoxyacetohydrazide (3′b). A white needle-shaped
1
crystal. Yield 85%. H NMR (CDCl3) δ/ppm: 7.75 (s, 1H, NH), 7.12
(d, J = 8.4 Hz, 2H, ArH), 6.80 (d, J = 8.4 Hz, 2H, ArH), 4.55 (s, 2H,
CH2), 3.92 (s, 2H, NH2), 2.30 (s, 3H, CH3); MS (EI) m/z (%): 181
(M + 1, 2), 180 (M, 14), 122 (2), 121 (12), 108 (100), 107 (17), 91
(54), 77 (10), 65 (14).
p-Methoxy-2-phenoxyacetohydrazide (3′c). A white needle-shaped
crystal. Yield 86%. 1H NMR (CDCl3) δ/ppm: 7.72 (s, 1H, NH),
6.82–6.90 (m, 4H, ArH), 4.53 (s, 2H, CH2), 3.91 (s, 2H, NH2), 3.77
(s, 3H, OCH3); MS (EI) m/z (%): 197 (M + 1, 4), 196 (M, 30), 138
(1), 137 (9), 124 (100), 109 (28), 107 (16), 92 (10), 77 (16), 64 (6).
(E)-N′-(1-(3-methyl-5-oxo-1-phenyl-4,5-dihydro-1H-pyrazol-4-yl)ethyli-
dene)-2-(p-tolyloxy)acetohydrazide (L2). A yellow needle-shaped
crystal. Yield 72%. m.p. 181–182°C. 1H NMR (CDCl3) δ/ppm:
12.35 (s, 1H, OH of enol-isomer), 8.59 (s, 1H, NH), 7.96 (d,
J = 7.6 Hz, 2H, ArH), 7.36 (t, J = 8.0 Hz, 2H, ArH), 7.13–7.16 (m,
3H, ArH), 6.85 (d, J = 8.6 Hz, 2H, ArH), 4.66 (s, 2H, CH2), 2.39 (s,
3H, CH3), 2.33 (s, 3H, CH3), 2.30 (s, 3H, CH3); 13C NMR (CDCl3)
δ/ppm: 167.78 (C=O), 166.53 (C5 of pyrazolone ring), 165.24
(C3 of pyrazolone ring), 154.79 (C1 of phenoxyl), 147.45 (C=N),
138.67 (C1 of 1-substituted aromatic ring), 131.91, 130.31,
128.79, 124.66, 119.18, 114.42 (aromatic ring carbons), 99.95
(CH2), 67.02 (C4 of pyrazolone ring), 20.53 (CH3), 17.17 (CH3),
14.27 (CH3); IR (KBr) ν/cmꢀ1: 3415, 3214, 2979, 1712, 1618,
1586, 1482, 1374, 1212, 752; MS (EI) m/z (%): 380 (M+ 2, 4), 379
(M+ 1, 26), 378 (M, 100), 257 (20), 243 (10), 199 (6), 126 (4), 72
(18), 59 (26); Anal. calcd for C21H22N4O3: C, 66.65; H, 5.86; N,
14.81. Found: C, 66.78; H, 5.77; N, 14.64.
p-Nitro-2-phenoxyacetohydrazide (3′d). A pale yellow crystal. Yield
82%. 1H NMR (CDCl3) δ/ppm: 8.25 (d, J= 8.0 Hz, 2H, ArH), 7.62 (s, 1H,
NH), 7.01 (d, J= 8.0 Hz, 2H, ArH), 4.67 (s, 2H, CH2), 3.95 (s, 2H, NH2);
MS (EI) m/z (%): 212 (M + 1, 4), 211 (M, 22), 153 (4), 152 (24), 123
(11), 122 (22), 106 (8), 92 (12), 76 (14), 73 (100), 65 (5).
p-Fluoro-2-phenoxyacetohydrazide (3′e).
A white needle-shaped
1
crystal. Yield 87%. H NMR (CDCl3) δ/ppm: 7.70 (s, 1H, NH), 7.02
(d, J = 8.0 Hz, 2H, ArH), 6.89 (d, J = 8.0 Hz, 2H, ArH), 4.54 (s, 2H,
CH2), 3.93 (s, 2H, NH2); MS (EI) m/z (%): 185 (M + 1, 2), 184 (20),
169 (2), 126 (4), 125 (24), 112 (100), 97(28), 95 (76), 83 (22), 75
(24), 73 (28).
p-Chloro-2-phenoxyacetohydrazide (3′f).
A white needle-shaped
(E)-N′-(1-(3-methyl-5-oxo-1-phenyl-4,5-dihydro-1H-pyrazol-4-yl)ethyli-
dene)-2-(p-tolyloxy)acetohydrazide (L3). A yellow crystal. Yield 70%.
m.p. 135–137°C. H NMR (CDCl3) δ/ppm: 12.38 (s, 1H, OH of enol-
1
crystal. Yield 90%. H NMR (CDCl3) δ/ppm: 7.72 (s, 1H, NH), 7.30
(d, J = 9.0 Hz, 2H, ArH), 6.87 (d, J = 9.0 Hz, 2H, ArH), 4.57 (s, 2H,
CH2), 3.95 (s, 2H, NH2); MS (EI) m/z (%): 202 (M + 2, 7), 200 (M,
20), 143 (6), 141 (17), 130 (33), 128 (100), 111 (34), 99 (4), 77
(7), 65 (4).
1
isomer), 8.67 (s, 1H, NH), 7.97 (d, J= 8.0 Hz, 2H, ArH), 7.36 (d,
J= 7.7 Hz, 2H, ArH), 7.14 (t, J= 7.4 Hz, 1H, ArH), 6.85–6.89 (m, 4H,
ArH), 4.63 (s, 2H, CH2), 3.79 (S, 3H, OCH3), 2.38 (s, 3H, CH3), 2.28 (s,
3H, CH3); 13C NMR (CDCl3) δ/ppm: 168.05 (C=O), 166.71 (C5 of
pyrazolone ring), 165.26 (C3 of pyrazolone ring), 154.89 (C1 of
phenoxyl), 151.01 (C4 of phenoxyl), 147.55 (C=N), 138.69 (C1 of 1-
substituted aromatic ring), 128.80, 124.66, 119.15, 115.62, 114.85 (ar-
omatic ring carbons), 99.75 (CH2), 67.54 (C4 of pyrazolone ring),
55.68 (OCH3), 17.14 (CH3), 14.26 (CH3); IR (KBr) ν/cmꢀ1: 3422, 3216,
2984, 1709, 1615, 1582, 1486, 1372, 1208, 749; MS (EI) m/z (%):
396 (M + 2, 4), 395 (M + 1, 26), 394 (M, 100), 257 (20), 243 (39), 215
(20), 199 (24), 123 (21), 109 (8), 77 (12); Anal. calcd for C21H22N4O4:
C, 63.95; H, 5.62; N, 14.20. Found: C, 63.78; H, 5.74; N, 14.04.
p-Bromo-2-phenoxyacetohydrazide (3′g). A white needle-shaped
1
crystal. Yield 87%. H NMR (CDCl3) δ/ppm: 7.69 (s, 1H, NH), 7.42
(d, J = 9.0 Hz, 2H, ArH), 6.80 (d, J = 9.0 Hz, 2H, ArH), 4.55 (s, 2H,
CH2), 3.93 (s, 2H, NH2); MS (EI) m/z (%): 246 (M + 1, 16), 244
(M – 1, 16),187 (16), 185 (18), 174 (97), 172 (100), 157 (49), 155
(46), 145 (8), 143 (8), 106 (7), 93 (11), 77 (18), 65 (24).
General procedure for the synthesis of the pyrazolone derivatives
(L1–7). The synthesis procedures for pyrazolone derivatives L1–7
are similar, so only the synthesis procedure of compound L1 is
shown for illustration. Compound 2 (4mmol, 0.864 g) was dis-
solved in 20 mL of absolute ethanol in a 100-mL three-neck flask.
Meanwhile, 2-phenoxyacetohydrazide (4mmol, 0.664 g) was dis-
solved in hot absolute ethanol (20 mL) in a 50 mL beaker, then
added to the above solution; 1 mL of glacial acetic acid was added
to the flask as a catalyst. The reaction mixture was heated to reflux
for 4 h at 105°C, then cooled to room temperature to form pale
yellow needle-shaped crystals. The crystals were filtered and
(E)-N′-(1-(3-methyl-5-oxo-1-phenyl-4,5-dihydro-1H-pyrazol-4-yl)ethyli-
dene)-2-(4-nitrophenoxy)acetohydrazide (L4). A pale yellow crystal.
1
Yield 68%. m.p. 241–242°C. H NMR (DMSO-d6) δ/ppm: 12.27 (s,
1H, OH of enol-isomer), 11.09 (S, 1H, NH), 8.26 (d, J = 9.2Hz, 2H,
ArH), 7.97 (d, J = 8.1 Hz, 2H, ArH), 7.39 (t, J = 7.9 Hz, 2H, ArH),
7.24 (d, J = 9.2 Hz, 2H, ArH), 7.13 (t, J = 7.4 Hz, 1H, ArH), 4.96 (s,
2H, CH2), 2.35 (s, 3H, CH3), 2.35 (s, 3H, CH3); 13C NMR (DMSO-
Luminescence 2014
Copyright © 2014 John Wiley & Sons, Ltd.
wileyonlinelibrary.com/journal/luminescence